• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚的乳腺癌幸存者都有谁?

Who are the breast cancer survivors in Malaysia?

作者信息

Ibrahim Nor Idawaty, Dahlui M, Aina E N, Al-Sadat N

机构信息

Ministry of Health, Kuala Lumpur, Malaysia.

出版信息

Asian Pac J Cancer Prev. 2012;13(5):2213-8. doi: 10.7314/apjcp.2012.13.5.2213.

DOI:10.7314/apjcp.2012.13.5.2213
PMID:22901196
Abstract

INTRODUCTION

Worldwide, breast cancer is the commonest cause of cancer death in women. However, the survival rate varies across regions at averages of 73%and 57% in the developed and developing countries, respectively.

OBJECTIVE

This study aimed to determine the survival rate of breast cancer among the women of Malaysia and characteristics of the survivors.

METHOD

A retrospective cohort study was conducted on secondary data obtained from the Breast Cancer Registry and medical records of breast cancer patients admitted to Hospital Kuala Lumpur from 2005 to 2009. Survival data were validated with National Birth and Death Registry. Statistical analysis applied logistic regression, the Cox proportional hazard model, the Kaplan-Meier method and log rank test.

RESULTS

A total of 868 women were diagnosed with breast cancer between January 2005 and December 2009, comprising 58%, 25% and 17% Malays, Chinese and Indians, respectively. The overall survival rate was 43.5% (CI 0.573-0.597), with Chinese, Indians and Malays having 5 year survival rates of 48.2% (CI 0.444-0.520), 47.2% (CI 0.432-0.512) and 39.7% (CI 0.373-0.421), respectively (p<0.05). The survival rate was lower as the stages increased, with the late stages were mostly seen among the Malays (46%), followed by Chinese (36%) and Indians (34%). Size of tumor>3.0cm; lymph node involvement, ERPR, and HER 2 status, delayed presentation and involvement of both breasts were among other factors that were associated with poor survival.

CONCLUSIONS

The overall survival rate of Malaysian women with breast cancer was lower than the western figures with Malays having the lowest because they presented at late stage, after a long duration of symptoms, had larger tumor size, and had more lymph nodes affected. There is an urgent need to conduct studies on why there is delay in diagnosis and treatment of breast cancer women in Malaysia.

摘要

引言

在全球范围内,乳腺癌是女性癌症死亡的最常见原因。然而,不同地区的生存率有所差异,发达国家和发展中国家的平均生存率分别为73%和57%。

目的

本研究旨在确定马来西亚女性乳腺癌的生存率及幸存者特征。

方法

对2005年至2009年期间从乳腺癌登记处及吉隆坡医院收治的乳腺癌患者病历中获取的二手数据进行回顾性队列研究。生存数据经国家出生和死亡登记处验证。统计分析采用逻辑回归、Cox比例风险模型、Kaplan-Meier方法和对数秩检验。

结果

2005年1月至2009年12月期间,共有868名女性被诊断为乳腺癌,其中马来人、华人、印度人分别占58%、25%和17%。总体生存率为43.5%(置信区间0.573 - 0.597),华人、印度人和马来人的5年生存率分别为48.2%(置信区间0.444 - 0.520)、47.2%(置信区间0.432 - 0.512)和39.7%(置信区间0.373 - 0.421)(p<0.05)。随着分期增加,生存率降低,晚期患者大多为马来人(46%),其次是华人(36%)和印度人(34%)。肿瘤大小>3.0cm、淋巴结受累、雌激素受体/孕激素受体(ER/PR)及人表皮生长因子受体2(HER 2)状态、就诊延迟和双侧乳房受累等是与生存率低相关的其他因素。

结论

马来西亚乳腺癌女性的总体生存率低于西方数据,其中马来人生存率最低,因为她们就诊时处于晚期,症状持续时间长,肿瘤尺寸大,且受影响的淋巴结更多。迫切需要开展研究,以了解马来西亚乳腺癌女性诊断和治疗延迟的原因。

相似文献

1
Who are the breast cancer survivors in Malaysia?马来西亚的乳腺癌幸存者都有谁?
Asian Pac J Cancer Prev. 2012;13(5):2213-8. doi: 10.7314/apjcp.2012.13.5.2213.
2
Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.N1期乳腺癌患者锁骨上淋巴结复发的预测因素
Asian Pac J Cancer Prev. 2013;14(4):2509-14. doi: 10.7314/apjcp.2013.14.4.2509.
3
Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.医院规模对乳腺癌治疗结果的影响:荷兰一项基于人群的研究。
Breast Cancer Res Treat. 2014 Aug;147(1):177-84. doi: 10.1007/s10549-014-3075-7. Epub 2014 Aug 9.
4
Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.长期乳腺癌幸存者初始治疗的接受地点及预后
PLoS One. 2017 Jan 13;12(1):e0170081. doi: 10.1371/journal.pone.0170081. eCollection 2017.
5
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.对11400例纯黏液性乳腺癌病例进行长期随访的回顾性研究。
Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18.
6
Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.基于人群的乳腺癌发病率和生存结局分析:诊断为乳腺小叶原位癌的女性。
Ann Surg Oncol. 2017 Sep;24(9):2509-2517. doi: 10.1245/s10434-017-5867-6. Epub 2017 Apr 28.
7
Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.马来西亚一家三级医院结直肠癌患者的生存率及生存预测因素
BMC Cancer. 2017 May 18;17(1):339. doi: 10.1186/s12885-017-3336-z.
8
Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.澳大利亚原住民和托雷斯海峡岛民妇女的乳房筛查与乳腺癌生存率
Asian Pac J Cancer Prev. 2012;13(1):147-55. doi: 10.7314/apjcp.2012.13.1.147.
9
The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.肿瘤与乳房体积比(TBR)可预测接受改良根治性乳房切除术的乳腺癌患者的癌症特异性生存率。
Tumour Biol. 2016 Jun;37(6):7493-500. doi: 10.1007/s13277-015-4382-2. Epub 2015 Dec 17.
10
Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre.马来西亚乳腺癌女性的生存分析:来自马来亚大学医学中心的结果。
Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):197-202.

引用本文的文献

1
Young Filipino breast cancer patients have worse survival outcomes.年轻的菲律宾乳腺癌患者有更差的生存结果。
Ecancermedicalscience. 2023 Nov 23;17:1639. doi: 10.3332/ecancer.2023.1639. eCollection 2023.
2
Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution.单一机构中乳腺癌的新辅助化疗反应、无病生存期和总生存期
Surg Open Sci. 2023 Jul 27;15:19-25. doi: 10.1016/j.sopen.2023.07.016. eCollection 2023 Sep.
3
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal.
一项关于亚洲女性乳腺癌现状的范围综述,特别关注尼泊尔。
Breast Cancer (Dove Med Press). 2022 Aug 26;14:229-246. doi: 10.2147/BCTT.S366530. eCollection 2022.
4
Influence of cultural practices on breast cancer risks, stage at presentation and outcome in a multi-ethnic developing country.文化习俗对一个多民族发展中国家乳腺癌风险、就诊时分期及预后的影响。
Oncol Lett. 2021 Nov;22(5):806. doi: 10.3892/ol.2021.13067. Epub 2021 Sep 23.
5
A comparison of breast cancer survival across different age groups: a multicentric database study in Penang, Malaysia.不同年龄组乳腺癌生存情况的比较:马来西亚槟城的多中心数据库研究。
Epidemiol Health. 2021;43:e2021038. doi: 10.4178/epih.e2021038. Epub 2021 May 25.
6
Net survival differences of breast cancer between stages at diagnosis and age groups in the east coast region of West Malaysia: a retrospective cohort study.马来西亚东海岸地区不同诊断分期和年龄组乳腺癌的净生存差异:一项回顾性队列研究。
BMJ Open. 2021 May 18;11(5):e043642. doi: 10.1136/bmjopen-2020-043642.
7
A path analytic model of health beliefs on the behavioral adoption of breast self-examination.关于乳房自我检查行为采用的健康信念路径分析模型。
AIMS Public Health. 2020 Dec 21;8(1):15-31. doi: 10.3934/publichealth.2021002. eCollection 2021.
8
Modelling excess mortality among breast cancer patients in the North East Region of Peninsular Malaysia, 2007-2011: a population-based study.2007-2011 年马来西亚半岛东北地区乳腺癌患者超额死亡率建模:一项基于人群的研究。
BMC Public Health. 2019 Dec 30;19(1):1754. doi: 10.1186/s12889-019-8113-2.
9
Using Google Trends Data to Study Public Interest in Breast Cancer Screening in Malaysia.利用谷歌趋势数据研究马来西亚公众对乳腺癌筛查的关注度。
Asian Pac J Cancer Prev. 2019 May 25;20(5):1427-1432. doi: 10.31557/APJCP.2019.20.5.1427.
10
Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia.马来西亚半岛东北部女性乳腺癌的生存时间及预后因素
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):497-502. doi: 10.22034/APJCP.2018.19.2.497.